Sales rise 676.47% to Rs 1.32 crore
Net profit of Venmax Drugs & Pharmaceuticals reported to Rs 0.02 crore in the quarter ended September 2025 as against net loss of Rs 0.30 crore during the previous quarter ended September 2024. Sales rose 676.47% to Rs 1.32 crore in the quarter ended September 2025 as against Rs 0.17 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales1.320.17 676 OPM %3.03-176.47 -PBDT0.04-0.30 LP PBT0.04-0.30 LP NP0.02-0.30 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
